BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1658 related articles for article (PubMed ID: 16672764)

  • 1. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.
    Henderson WR; Tang LO; Chu SJ; Tsao SM; Chiang GK; Jones F; Jonas M; Pae C; Wang H; Chi EY
    Am J Respir Crit Care Med; 2002 Jan; 165(1):108-16. PubMed ID: 11779739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.
    Henderson WR; Chiang GK; Tien YT; Chi EY
    Am J Respir Crit Care Med; 2006 Apr; 173(7):718-28. PubMed ID: 16387808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of budesonide on airway inflammation and airway remodeling in the ovalbumin sensitized and challenged mice].
    Shen HH; Wang SB
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):154-9. PubMed ID: 15854408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of montelukast on airway remodeling and the expression of interleukins and transforming growth factor-beta2 mRNA].
    Bai JW; Deng WW; Wu HC
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):524-8. PubMed ID: 15388000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
    Wong WS; Zhu H; Liao W
    Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3.
    Kiwamoto T; Ishii Y; Morishima Y; Yoh K; Kikuchi N; Haraguchi N; Masuko H; Kawaguchi M; Nomura A; Sakamoto T; Takahashi S; Hizawa N
    Clin Exp Allergy; 2011 Jan; 41(1):116-28. PubMed ID: 20636401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
    Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
    Shin IS; Jeon WY; Shin HK; Lee MY
    Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of selective cysteinyl leukotriene receptor antagonists on airway inflammation and matrix metalloproteinase expression in a mouse asthma model.
    Hsu CH; Hu CM; Lu KH; Yang SF; Tsai CH; Ko CL; Sun HL; Lue KH
    Pediatr Neonatol; 2012 Aug; 53(4):235-44. PubMed ID: 22964281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice.
    Yamabayashi C; Koya T; Kagamu H; Kawakami H; Kimura Y; Furukawa T; Sakagami T; Hasegawa T; Sakai Y; Matsumoto K; Nakayama M; Gelfand EW; Suzuki E; Narita I
    Am J Respir Cell Mol Biol; 2012 Aug; 47(2):170-7. PubMed ID: 22403804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model.
    Huerta-Yepez S; Baay-Guzman GJ; Garcia-Zepeda R; Hernandez-Pando R; Vega MI; Gonzalez-Bonilla C; Bonavida B
    Clin Immunol; 2008 Nov; 129(2):313-24. PubMed ID: 18793875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Oryza sativa extract on the progression of airway inflammation and remodeling in an experimental animal model of asthma.
    Lee SH; Choi SM; Sohn YS; Kang KK; Yoo M
    Planta Med; 2006 Apr; 72(5):405-10. PubMed ID: 16557453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.
    Holgate ST; Peters-Golden M; Panettieri RA; Henderson WR
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S18-34; discussion S34-6. PubMed ID: 12532084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of furosemide on allergic asthmatic responses in mice.
    Wang S; Xiang YY; Ellis R; Wattie J; Feng M; Inman MD; Lu WY
    Clin Exp Allergy; 2011 Oct; 41(10):1456-67. PubMed ID: 21729180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
    Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
    Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
    Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
    Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidermal growth factor receptor mediates allergic airway remodelling in the rat.
    Tamaoka M; Hassan M; McGovern T; Ramos-Barbón D; Jo T; Yoshizawa Y; Tolloczko B; Hamid Q; Martin JG
    Eur Respir J; 2008 Nov; 32(5):1213-23. PubMed ID: 18653647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571.
    Blain JF; Sirois P
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):361-8. PubMed ID: 10913229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.